Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Triamcinolone Acetonide Nasal Spray in Seasonal Allergic Rhinitis
NCT00987233Phase 3Completed
- Sponsor
- Apotex Inc.
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in seasonal allergic rhinitis (SAR), sponsored by Apotex Inc.. Status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00987233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987233.